Annual General Meeting
Dear Shareholders,
the Annual General Shareholders’ Meeting of Epigenomics AG has taken place on June 12, 2020, as a virtual event without the physical presence of the shareholders in Munich. The presence amounted to around 40% of the share capital. Shareholders approved all agenda items according to the Board’s proposal.
| Voting results of the Annual General Shareholders’ Meeting 2020 (German only) | |
| Invitation to the Annual General Shareholders’ Meeting 2020 of Epigenomics AG | |
| Curriculum vitae of Mr Alexander Link | |
| Reports of the Executive Board on agenda items 6, 7 and 8 | |
| Annual Report 2019 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
| Financial Statements 2019 (German HGB) incl. Key features of the internal control and risk management system (German version) |
|
| Explanatory Report by the Management Board on Disclosures Pusuant to Section 289a (1), Section 315a (1) HGB (German Version) | |
| Information on data protection | |
| Access to the Investor Portal of Epigenomics AG | Link |
Corporate Governance/Declaration of Governance
| 2019 | |
| Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) | |
| Update of the Declaration of Compliance pursuant to Section 161 of the German Stock Corporation Act (AktG) – March 2020 | |
| Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
| Explanation of Shareholders’ rights | |
| Articles of Association |